| pubmed-article:20066812 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20066812 | lifeskim:mentions | umls-concept:C0036341 | lld:lifeskim |
| pubmed-article:20066812 | lifeskim:mentions | umls-concept:C0040615 | lld:lifeskim |
| pubmed-article:20066812 | lifeskim:mentions | umls-concept:C0205245 | lld:lifeskim |
| pubmed-article:20066812 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:20066812 | lifeskim:mentions | umls-concept:C0010362 | lld:lifeskim |
| pubmed-article:20066812 | lifeskim:mentions | umls-concept:C0079411 | lld:lifeskim |
| pubmed-article:20066812 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:20066812 | pubmed:dateCreated | 2010-1-13 | lld:pubmed |
| pubmed-article:20066812 | pubmed:abstractText | The purpose of this study was to compare outpatients with stable schizophrenia who were treated with either first or second generation antipsychotics in terms of executive functions, social functioning and quality of life. | lld:pubmed |
| pubmed-article:20066812 | pubmed:language | ita | lld:pubmed |
| pubmed-article:20066812 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20066812 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20066812 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20066812 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20066812 | pubmed:issn | 0035-6484 | lld:pubmed |
| pubmed-article:20066812 | pubmed:author | pubmed-author:RoccaPaolaP | lld:pubmed |
| pubmed-article:20066812 | pubmed:author | pubmed-author:MontemagniCri... | lld:pubmed |
| pubmed-article:20066812 | pubmed:author | pubmed-author:CastagnaFilom... | lld:pubmed |
| pubmed-article:20066812 | pubmed:author | pubmed-author:BirindelliNad... | lld:pubmed |
| pubmed-article:20066812 | pubmed:author | pubmed-author:MingroneCinzi... | lld:pubmed |
| pubmed-article:20066812 | pubmed:author | pubmed-author:SigaudoMonica... | lld:pubmed |
| pubmed-article:20066812 | pubmed:author | pubmed-author:ZappiaSerenaS | lld:pubmed |
| pubmed-article:20066812 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20066812 | pubmed:volume | 44 | lld:pubmed |
| pubmed-article:20066812 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20066812 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20066812 | pubmed:pagination | 110-6 | lld:pubmed |
| pubmed-article:20066812 | pubmed:meshHeading | pubmed-meshheading:20066812... | lld:pubmed |
| pubmed-article:20066812 | pubmed:meshHeading | pubmed-meshheading:20066812... | lld:pubmed |
| pubmed-article:20066812 | pubmed:meshHeading | pubmed-meshheading:20066812... | lld:pubmed |
| pubmed-article:20066812 | pubmed:meshHeading | pubmed-meshheading:20066812... | lld:pubmed |
| pubmed-article:20066812 | pubmed:meshHeading | pubmed-meshheading:20066812... | lld:pubmed |
| pubmed-article:20066812 | pubmed:meshHeading | pubmed-meshheading:20066812... | lld:pubmed |
| pubmed-article:20066812 | pubmed:meshHeading | pubmed-meshheading:20066812... | lld:pubmed |
| pubmed-article:20066812 | pubmed:articleTitle | [Functional outcome in schizophrenia: a comparative cross-sectional study on first versus second generation antipsychotics]. | lld:pubmed |
| pubmed-article:20066812 | pubmed:affiliation | Dipartimento di Neuroscienze, Sezione di Psichiatria, Università di Torino. | lld:pubmed |
| pubmed-article:20066812 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20066812 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:20066812 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:20066812 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:20066812 | pubmed:publicationType | Multicenter Study | lld:pubmed |
